Ownership

Stephen Davis

Insider Reports History

Entity: Individual
Location: Acadia Pharmaceuticals Inc., 12830 El Camino Real, Suite 400, San Diego, CA
Signature: /s/ Jennifer J. Rhodes, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Stephen Davis:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
ACADIA PHARMACEUTICALS INC	CEO, Director	Common Stock	187K	$2.85M	$15.28	Aug 19, 2024	Direct
ACADIA PHARMACEUTICALS INC	CEO, Director	Restricted Stock Units	67.2K	$1.2M	$17.87	May 1, 2024	Direct
HERON THERAPEUTICS, INC. /DE/	Director	Stock Option (Right to Buy)	77.2K	$137K	$1.78	Dec 16, 2022	Direct
HERON THERAPEUTICS, INC. /DE/	Director	Common Stock	52K	$112K	$2.15	Dec 16, 2022	Direct
ACADIA PHARMACEUTICALS INC	CEO, Director	Stock Option (Right to Buy)	286K			Mar 25, 2024	Direct
BELLICUM PHARMACEUTICALS, INC	Director	Common Stock	137K			Jan 3, 2023	Direct

Previous1Next

Showing 1 to 6 of 6 entries

Insider Reports Filed by Stephen Davis

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
ACAD	ACADIA PHARMACEUTICALS INC	Aug 16, 2024	3	-$485K	4	Aug 20, 2024	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	May 1, 2024	3	-$194K	4	May 3, 2024	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	Apr 5, 2024	6	-$475K	4	Apr 9, 2024	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	Mar 25, 2024	3	-$317K	4	Mar 27, 2024	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	Feb 23, 2024	3	-$138K	4	Feb 27, 2024	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	Jan 6, 2024	3	-$112K	4	Jan 9, 2024	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	Oct 5, 2023	3	-$1.13M	4	Oct 6, 2023	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	Jul 14, 2023	3	-$927K	4	Jul 18, 2023	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	Jul 11, 2023	2	-$1.79M	4	Jul 13, 2023	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	May 1, 2023	2	$0	4	May 3, 2023	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	Apr 29, 2023	3	-$165K	4	May 2, 2023	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	Apr 5, 2023	3	-$156K	4	Apr 7, 2023	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	Feb 23, 2023	3	-$72.3K	4	Feb 27, 2023	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	Jan 6, 2023	3	-$66.9K	4	Jan 10, 2023	CEO, Director
BLCM	BELLICUM PHARMACEUTICALS, INC	Jan 3, 2023	1	$0	4	Jan 5, 2023	Director
HRTX	HERON THERAPEUTICS, INC. /DE/	Dec 16, 2022	2	$0	4	Dec 20, 2022	Director
ACAD	ACADIA PHARMACEUTICALS INC	Oct 15, 2022	3	-$44.3K	4	Oct 18, 2022	CEO, Director
BLCM	BELLICUM PHARMACEUTICALS, INC	Sep 1, 2022	1	$0	4	Sep 2, 2022	Director
BLCM	BELLICUM PHARMACEUTICALS, INC	Jun 15, 2022	1	$0	4	Jun 16, 2022	Director
ACAD	ACADIA PHARMACEUTICALS INC	Apr 29, 2022	3	-$99.7K	4	May 3, 2022	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	Apr 5, 2022	3	$0	4	Apr 7, 2022	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	Feb 23, 2022	3	-$93.5K	4	Feb 25, 2022	CEO, Director
ACAD	ACADIA PHARMACEUTICALS INC	Jan 6, 2022	3	-$85.7K	4	Jan 10, 2022	CEO, Director
BLCM	BELLICUM PHARMACEUTICALS, INC	Jan 4, 2022	2	$0	4	Jan 6, 2022	Director
HRTX	HERON THERAPEUTICS, INC. /DE/	Dec 22, 2021	2	$0	4	Dec 23, 2021	Director
ACAD	ACADIA PHARMACEUTICALS INC	Oct 15, 2021	3	-$51.6K	4	Oct 19, 2021	CEO, Director
BLCM	BELLICUM PHARMACEUTICALS, INC	Jun 15, 2021	1	$0	4	Jul 7, 2021	Director